Contrast enhanced ultrasound in the detection of liver metastases: A prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100)

European Radiology

Volumn 21, Issue 8, 2011, Pages 1739-1746

  Correas, Jean Michel ^a   Low, Gavin ^b,c,n   Needleman, Laurence ^e   Robbin, Michelle L ^f   Cosgrove, David ^g   Sidhu, Paul S ^h   Harvey, Chris J ^g   Albrecht, Thomas ⁱ   Jakobsen, Jarl A ^j   Brabrand, Knut ^j   Jenett, Manfred ^k   Bates, Jane ^l   Claudon, Michel ^m   Leen, Edward ^d,g  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

^h VIVANTES KLINIKUM NEUKÖLLN   (Germany)

ⁱ Division of Diagnostics and Intervention   (Germany)

^j OSLO UNIVERSITY HOSPITAL   (Norway)

^k UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^l ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^m CHU NANCY BRABOIS   (France)

ⁿ UNIVERSITY OF ALBERTA   (Canada)

more..

Author keywords

Contrast media; Liver; Liver neoplasms; Microbubbles; Neoplasm metastasis; Ultrasonography

Indexed keywords

CONTRAST MEDIUM; PERFLUBUTANE;

ADULT; AGED; AIR TEMPERATURE; ARTICLE; BONE PAIN; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG FEVER; ERUCTATION; FALSE POSITIVE RESULT; FEMALE; FLATULENCE; HEADACHE; HUMAN; INJECTION PAIN; INSOMNIA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROBUBBLE; MULTICENTER STUDY; MUSCLE HYPERTONIA; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA; TASTE; TUMOR VOLUME; ULTRASOUND;

AGED; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; FERRIC COMPOUNDS; HUMANS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICROBUBBLES; MIDDLE AGED; OXIDES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80052686690     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2114-6     Document Type: Article

References (13)

1. Yanagisawa K, Moriyasu F, Miyahara T et al (2007) Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 33:318-325. (Pubitemid 46240604)
2. Kindberg GM, Tolleshaug H, Roos N et al (2003) Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of the liver to phagocytose or degrade albumin microspheres. Cell Tissue Res 312:49-54. (Pubitemid 36578845)
3. Watanabe R, Matsumura M, Munemasa T et al (2007) Mechanism of hepatic parenchyma specific contrast of microbubble based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 42:643-651. (Pubitemid 47262933)
4. Nakano H, Ishida Y, Hatakeyama T et al (2008) Contrastenhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases. World J Gastroenterol 14:3207- 3211.
5. Sugimoto K, Shiraishi J, Moriyasu F et al (2009) Computer-aided diagnosis of focal liver lesions by use of physicians' subjective classification of echogenic patterns in baseline and contrastenhanced ultrasonography. Acad Radiol 16:401-411.
6. Luo W, Numata K, Morimoto M et al (2009) Focal liver tumours: Characterization with 3D perflubutane microbubble contrast agent enhanced US versus 3D contrast enhanced multidetector CT. Radiology 251:287-295.
7. Hatanaka K, Kudo M, Minami Y et al (2008) Differential diagnosis of hepatic tumours: Value of contrast enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology Suppl 51:61-69. (Pubitemid 351821844)
8. Sugimoto K, Shiraishi J, Moriyasu F et al (2009) Improved detection of hepatic metastases with contrast-enhanced low mechanical-index pulse inversion ultrasonography during the liver-specific phase of sonazoid: observer performance study with JAFROC analysis. Acad Radiol 16:798-809.
9. Luo W, Numata K, Kondo M et al (2009) Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumours in the late phase by intermittent imaging with a high mechanical index. J Ultrasound Med 28:439-48.
10. Nino-Murcia M, Olcott EW, Jeffrey RB Jr et al (2000) Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology 215:746-51. (Pubitemid 30346009)
11. Elsayes KM, Narra VR, Yuming Y et al (2005) Diagnostic value of enhancement pattern approach with contrast enhanced 3D gradient echo MR imaging. Radiographics 25:1299-1320. (Pubitemid 41695347)
12. Edey AJ, Ryan SM, Beese RC et al (2008) Ultrasound imaging of liver metastases in the delayed parenchymal phase following administration of Sonazoid using a destructive mode technique (Agent Detection Imaging). Clin Radiol 63:1112-20.
13. Leen E, Kumar S, Khan SA et al (2009) Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumours. World J Gastroenterol 15:289-99.